All-trans retinoic acid and late relapses in acute promyelocytic leukemia

Very long-term follow-up of the North American Intergroup Study I0129

Dan Douer, Lynette N. Zickl, Charles A. Schiffer, Fredrick R. Appelbaum, James H. Feusner, Lois Shepherd, Cheryl L. Willman, Clara D. Bloomfield, Elisabeth M. Paietta, Robert E. Gallagher, Jae H. Park, Jacob M. Rowe, Peter H. Wiernik, Martin S. Tallman

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

We report a long-term follow-up (median 11.8 years) of the First North American Intergroup Study. 379 patients were randomized to induction with ATRA or to chemotherapy. All complete responders (CR) received consolidation chemotherapy, then randomized to 1 year ATRA or observation. 245 patients received ATRA sometime during the study: 195 (80%) achieved a CR. Nine (4.6%) relapsed late (>3 years from CR), the last occurred after 4.6 years; 7 of them were still alive after 5.5-15 years. In APL patients, late relapses are uncommon, and those who sustain CR >5 years can be considered cured.

Original languageEnglish (US)
Pages (from-to)795-801
Number of pages7
JournalLeukemia Research
Volume37
Issue number7
DOIs
StatePublished - Jul 2013

Fingerprint

Acute Promyelocytic Leukemia
Tretinoin
Recurrence
Consolidation Chemotherapy
Observation
Drug Therapy

Keywords

  • Acute promyelocytic leukemia
  • All-trans retinoic acid
  • Late relapse

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

All-trans retinoic acid and late relapses in acute promyelocytic leukemia : Very long-term follow-up of the North American Intergroup Study I0129. / Douer, Dan; Zickl, Lynette N.; Schiffer, Charles A.; Appelbaum, Fredrick R.; Feusner, James H.; Shepherd, Lois; Willman, Cheryl L.; Bloomfield, Clara D.; Paietta, Elisabeth M.; Gallagher, Robert E.; Park, Jae H.; Rowe, Jacob M.; Wiernik, Peter H.; Tallman, Martin S.

In: Leukemia Research, Vol. 37, No. 7, 07.2013, p. 795-801.

Research output: Contribution to journalArticle

Douer, D, Zickl, LN, Schiffer, CA, Appelbaum, FR, Feusner, JH, Shepherd, L, Willman, CL, Bloomfield, CD, Paietta, EM, Gallagher, RE, Park, JH, Rowe, JM, Wiernik, PH & Tallman, MS 2013, 'All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129', Leukemia Research, vol. 37, no. 7, pp. 795-801. https://doi.org/10.1016/j.leukres.2013.03.001
Douer, Dan ; Zickl, Lynette N. ; Schiffer, Charles A. ; Appelbaum, Fredrick R. ; Feusner, James H. ; Shepherd, Lois ; Willman, Cheryl L. ; Bloomfield, Clara D. ; Paietta, Elisabeth M. ; Gallagher, Robert E. ; Park, Jae H. ; Rowe, Jacob M. ; Wiernik, Peter H. ; Tallman, Martin S. / All-trans retinoic acid and late relapses in acute promyelocytic leukemia : Very long-term follow-up of the North American Intergroup Study I0129. In: Leukemia Research. 2013 ; Vol. 37, No. 7. pp. 795-801.
@article{791aac7fa88d44b9996be378d9e579ee,
title = "All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129",
abstract = "We report a long-term follow-up (median 11.8 years) of the First North American Intergroup Study. 379 patients were randomized to induction with ATRA or to chemotherapy. All complete responders (CR) received consolidation chemotherapy, then randomized to 1 year ATRA or observation. 245 patients received ATRA sometime during the study: 195 (80{\%}) achieved a CR. Nine (4.6{\%}) relapsed late (>3 years from CR), the last occurred after 4.6 years; 7 of them were still alive after 5.5-15 years. In APL patients, late relapses are uncommon, and those who sustain CR >5 years can be considered cured.",
keywords = "Acute promyelocytic leukemia, All-trans retinoic acid, Late relapse",
author = "Dan Douer and Zickl, {Lynette N.} and Schiffer, {Charles A.} and Appelbaum, {Fredrick R.} and Feusner, {James H.} and Lois Shepherd and Willman, {Cheryl L.} and Bloomfield, {Clara D.} and Paietta, {Elisabeth M.} and Gallagher, {Robert E.} and Park, {Jae H.} and Rowe, {Jacob M.} and Wiernik, {Peter H.} and Tallman, {Martin S.}",
year = "2013",
month = "7",
doi = "10.1016/j.leukres.2013.03.001",
language = "English (US)",
volume = "37",
pages = "795--801",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - All-trans retinoic acid and late relapses in acute promyelocytic leukemia

T2 - Very long-term follow-up of the North American Intergroup Study I0129

AU - Douer, Dan

AU - Zickl, Lynette N.

AU - Schiffer, Charles A.

AU - Appelbaum, Fredrick R.

AU - Feusner, James H.

AU - Shepherd, Lois

AU - Willman, Cheryl L.

AU - Bloomfield, Clara D.

AU - Paietta, Elisabeth M.

AU - Gallagher, Robert E.

AU - Park, Jae H.

AU - Rowe, Jacob M.

AU - Wiernik, Peter H.

AU - Tallman, Martin S.

PY - 2013/7

Y1 - 2013/7

N2 - We report a long-term follow-up (median 11.8 years) of the First North American Intergroup Study. 379 patients were randomized to induction with ATRA or to chemotherapy. All complete responders (CR) received consolidation chemotherapy, then randomized to 1 year ATRA or observation. 245 patients received ATRA sometime during the study: 195 (80%) achieved a CR. Nine (4.6%) relapsed late (>3 years from CR), the last occurred after 4.6 years; 7 of them were still alive after 5.5-15 years. In APL patients, late relapses are uncommon, and those who sustain CR >5 years can be considered cured.

AB - We report a long-term follow-up (median 11.8 years) of the First North American Intergroup Study. 379 patients were randomized to induction with ATRA or to chemotherapy. All complete responders (CR) received consolidation chemotherapy, then randomized to 1 year ATRA or observation. 245 patients received ATRA sometime during the study: 195 (80%) achieved a CR. Nine (4.6%) relapsed late (>3 years from CR), the last occurred after 4.6 years; 7 of them were still alive after 5.5-15 years. In APL patients, late relapses are uncommon, and those who sustain CR >5 years can be considered cured.

KW - Acute promyelocytic leukemia

KW - All-trans retinoic acid

KW - Late relapse

UR - http://www.scopus.com/inward/record.url?scp=84878516956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878516956&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2013.03.001

DO - 10.1016/j.leukres.2013.03.001

M3 - Article

VL - 37

SP - 795

EP - 801

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 7

ER -